We are a new startup that it is going to be working on pharmaceutical drugs that are are going to be used for oral solutions
Entera Bio intends to develop world class oral formulations of large molecule drugs which are both currently marketed and in development
Dr. Phillip Schwartz will serve as Entera's Chief Executive Officer. Dr. Schwartz has over 10 years of experience in the pharmaceutical and biotech industries and served as a lecturer at Harvard Medical School. Prior to joining Entera, Dr. Schwartz served as the Scientific and Medical Development Manager for Endo Pharmaceuticals (NasdaqGS: ENDP).
Entera Bio is currently involved in the development of an oral medication.
We are just starting out and we want to be professional and cutting edge firm.
Vertel ons iets meer over jezelf en de mensen die je bereikt
Are market for our website is Big Pharmaceutical Companies, Investors and the general population.